2Q51 - JenaLib

Asym.Unit - manually (Jmol Viewer)

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Title :   ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF AN ASPARTOACYLASE FROM HOMO SAPIENS

Authors :   E. J. Levin, D. A. Kondrashov, G. E. Wesenberg, G. N. Phillips Jr. , Cent Eukaryotic Structural Genomics (Cesg)

Date :   31 May 07 (Deposition) - 19 Jun 07 (Release) - 10 Aug 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.80

Chains :   Asym. Unit : A,B  (16x)
Biol. Unit 1: A,B  (1x)

Keywords :   Ensemble Refinement, Refinement Methodology Development, Canavan Disease, N-Acetyl-L-Aspartate, Zinc-Dependent Hydrolase, Aspartoacylase Family, Aminoacylase-2, Acy2, Aspa, Structural Genomics, Protein Structure Initiative, Psi, Center For Eukaryotic Structural Genomics, Cesg, Hydrolase (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   E. J. Levin, D. A. Kondrashov, G. E. Wesenberg, G. N. Phillips
Ensemble Refinement Of Protein Crystal Structures: Validation And Application.
Structure V. 15 1040 2007
PubMed-ID: 17850744 | Reference-DOI: 10.1016/J.STR.2007.06.019
(for further references see the PDB file header)

Molecule 1 - ASPARTOACYLASE
	Chains	:	A, B
	EC Number	:	3.5.1.15
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Plasmid	:	PVP33K
	Expression System Strain	:	BL834 P(RARE2)
	Expression System Taxid	:	562
	Expression System Vector Type	:	PLASMID
	Gene	:	ASPA, ACY2, ASP
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	AMINOACYLASE-2, ACY-2

		1	2
Asymmetric Unit (16x)	:	A	B
Biological Unit 1 (1x)	:	A	B

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (3, 22)

No.	Name	Count	Type	Full Name
1	MSE	12	Mod. Amino Acid	SELENOMETHIONINE
2	PO4	8	Ligand/Ion	PHOSPHATE ION
3	ZN	2	Ligand/Ion	ZINC ION

Biological Unit 1 (2, 20)

No.	Name	Count	Type	Full Name
1	MSE	12	Mod. Amino Acid	SELENOMETHIONINE
2	PO4	8	Ligand/Ion	PHOSPHATE ION
3	ZN	-1	Ligand/Ion	ZINC ION

Asymmetric Unit (10, 10)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	HIS A:21 , GLU A:24 , ARG A:63 , HIS A:116	BINDING SITE FOR RESIDUE ZN A 314
02	AC2	SOFTWARE	ASN A:70 , ILE A:127 , ILE A:157 , ARG A:168	BINDING SITE FOR RESIDUE PO4 A 315
03	AC3	SOFTWARE	HIS A:21 , ARG A:63 , ASP A:68 , ASN A:70 , ARG A:71 , TYR A:288	BINDING SITE FOR RESIDUE PO4 A 316
04	AC4	SOFTWARE	LYS A:103 , ASP A:104 , LYS A:163 , TYR A:164 , LYS B:163	BINDING SITE FOR RESIDUE PO4 A 317
05	AC5	SOFTWARE	ARG A:71 , HIS A:159	BINDING SITE FOR RESIDUE PO4 A 318
06	AC6	SOFTWARE	HIS B:21 , GLU B:24 , HIS B:116 , PO4 B:315	BINDING SITE FOR RESIDUE ZN B 314
07	AC7	SOFTWARE	GLU B:24 , ARG B:63 , ASN B:117 , THR B:118 , GLU B:178 , GLU B:285 , ZN B:314	BINDING SITE FOR RESIDUE PO4 B 315
08	AC8	SOFTWARE	HIS B:21 , ARG B:63 , ASP B:68 , ASN B:70 , ARG B:71 , LYS B:291	BINDING SITE FOR RESIDUE PO4 B 316
09	AC9	SOFTWARE	LYS B:103 , ASP B:104 , LYS B:163 , TYR B:164 , SER B:169 , HOH B:338	BINDING SITE FOR RESIDUE PO4 B 317
10	BC1	SOFTWARE	ARG B:71 , HIS B:159 , LYS B:228 , HOH B:329	BINDING SITE FOR RESIDUE PO4 B 318

(no "SS Bond" information available for 2Q51)

Asymmetric Unit

No.	Model	Residues
1	1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16	Gly A:101	-	Pro A:102
2	1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16	Ala A:148	-	Pro A:149
3	1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16	Gly A:180	-	Pro A:181
4	1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16	Gly B:101	-	Pro B:102
5	1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16	Ala B:148	-	Pro B:149
6	1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16	Gly B:180	-	Pro B:181

Asymmetric Unit (43, 86)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_039079	I	16	T	ACY2_HUMAN	Disease (CAND)	769653717	A/B	I	16	T
02	UniProt	VAR_016778	H	21	P	ACY2_HUMAN	Disease (CAND)	---	A/B	H	21	P
03	UniProt	VAR_016782	E	24	G	ACY2_HUMAN	Disease (CAND)	104894551	A/B	E	24	G
04	UniProt	VAR_078086	E	24	K	ACY2_HUMAN	Disease (CAND)	---	A/B	E	24	K
05	UniProt	VAR_039080	G	27	R	ACY2_HUMAN	Disease (CAND)	766328537	A/B	G	27	R
06	UniProt	VAR_078087	L	30	P	ACY2_HUMAN	Disease (CAND)	---	A/B	L	30	P
07	UniProt	VAR_016779	A	57	T	ACY2_HUMAN	Disease (CAND)	---	A/B	A	57	T
08	UniProt	VAR_078088	A	57	V	ACY2_HUMAN	Disease (CAND)	---	A/B	A	57	V
09	UniProt	VAR_078089	R	63	T	ACY2_HUMAN	Disease (CAND)	---	A/B	R	63	T
10	UniProt	VAR_016783	D	68	A	ACY2_HUMAN	Disease (CAND)	---	A/B	D	68	A
11	UniProt	VAR_078090	L	69	R	ACY2_HUMAN	Disease (CAND)	776777887	A/B	L	69	R
12	UniProt	VAR_078091	G	101	V	ACY2_HUMAN	Disease (CAND)	---	A/B	G	101	V
13	UniProt	VAR_039081	D	114	E	ACY2_HUMAN	Disease (CAND)	---	A/B	D	114	E
14	UniProt	VAR_016784	D	114	Y	ACY2_HUMAN	Disease (CAND)	---	A/B	D	114	Y
15	UniProt	VAR_039082	G	123	E	ACY2_HUMAN	Disease (CAND)	---	A/B	G	123	E
16	UniProt	VAR_078092	E	129	K	ACY2_HUMAN	Disease (CAND)	773049803	A/B	E	129	K
17	UniProt	VAR_004995	I	143	T	ACY2_HUMAN	Disease (CAND)	777936704	A/B	I	143	T
18	UniProt	VAR_004996	C	152	R	ACY2_HUMAN	Disease (CAND)	104894548	A/B	C	152	R
19	UniProt	VAR_016785	C	152	W	ACY2_HUMAN	Disease (CAND)	---	A/B	C	152	W
20	UniProt	VAR_039083	C	152	Y	ACY2_HUMAN	Disease (CAND)	---	A/B	C	152	Y
21	UniProt	VAR_039084	R	168	C	ACY2_HUMAN	Disease (CAND)	---	A/B	R	168	C
22	UniProt	VAR_016780	R	168	H	ACY2_HUMAN	Disease (CAND)	770706390	A/B	R	168	H
23	UniProt	VAR_078093	I	170	T	ACY2_HUMAN	Disease (CAND)	144321760	A/B	I	170	T
24	UniProt	VAR_078094	I	177	T	ACY2_HUMAN	Disease (CAND)	---	A/B	I	177	T
25	UniProt	VAR_078095	G	180	V	ACY2_HUMAN	Disease (CAND)	---	A/B	G	180	V
26	UniProt	VAR_016781	P	181	T	ACY2_HUMAN	Disease (CAND)	786204572	A/B	P	181	T
27	UniProt	VAR_039085	P	183	H	ACY2_HUMAN	Disease (CAND)	---	A/B	P	183	H
28	UniProt	VAR_039086	V	186	F	ACY2_HUMAN	Disease (CAND)	---	A/B	V	186	F
29	UniProt	VAR_039087	M	195	R	ACY2_HUMAN	Disease (CAND)	---	A/B	M	195	R
30	UniProt	VAR_078096	D	204	H	ACY2_HUMAN	Disease (CAND)	---	A/B	D	204	H
31	UniProt	VAR_016786	Y	231	C	ACY2_HUMAN	Disease (CAND)	104894550	A/B	Y	231	C
32	UniProt	VAR_016787	H	244	R	ACY2_HUMAN	Disease (CAND)	---	A/B	H	244	R
33	UniProt	VAR_078097	Q	248	R	ACY2_HUMAN	Disease (CAND)	---	A/B	Q	248	R
34	UniProt	VAR_016788	D	249	V	ACY2_HUMAN	Disease (CAND)	104894552	A/B	D	249	V
35	UniProt	VAR_004998	G	274	R	ACY2_HUMAN	Disease (CAND)	761064915	A/B	G	274	R
36	UniProt	VAR_039088	P	280	L	ACY2_HUMAN	Disease (CAND)	---	A/B	P	280	L
37	UniProt	VAR_039089	P	280	S	ACY2_HUMAN	Disease (CAND)	750505963	A/B	P	280	S
38	UniProt	VAR_004999	E	285	A	ACY2_HUMAN	Disease (CAND)	28940279	A/B	E	285	A
39	UniProt	VAR_078098	A	286	D	ACY2_HUMAN	Disease (CAND)	---	A/B	A	286	D
40	UniProt	VAR_039090	A	287	T	ACY2_HUMAN	Disease (CAND)	774323189	A/B	A	287	T
41	UniProt	VAR_005000	F	295	S	ACY2_HUMAN	Disease (CAND)	---	A/B	F	295	S
42	UniProt	VAR_005001	A	305	E	ACY2_HUMAN	Disease (CAND)	28940574	A/B	A	305	E
43	UniProt	VAR_039091	C	310	G	ACY2_HUMAN	Polymorphism	376854191	A/B	C	310	G

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (43, 86)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_039079	I	16	T	ACY2_HUMAN	Disease (CAND)	769653717	A/B	I	16	T
02	UniProt	VAR_016778	H	21	P	ACY2_HUMAN	Disease (CAND)	---	A/B	H	21	P
03	UniProt	VAR_016782	E	24	G	ACY2_HUMAN	Disease (CAND)	104894551	A/B	E	24	G
04	UniProt	VAR_078086	E	24	K	ACY2_HUMAN	Disease (CAND)	---	A/B	E	24	K
05	UniProt	VAR_039080	G	27	R	ACY2_HUMAN	Disease (CAND)	766328537	A/B	G	27	R
06	UniProt	VAR_078087	L	30	P	ACY2_HUMAN	Disease (CAND)	---	A/B	L	30	P
07	UniProt	VAR_016779	A	57	T	ACY2_HUMAN	Disease (CAND)	---	A/B	A	57	T
08	UniProt	VAR_078088	A	57	V	ACY2_HUMAN	Disease (CAND)	---	A/B	A	57	V
09	UniProt	VAR_078089	R	63	T	ACY2_HUMAN	Disease (CAND)	---	A/B	R	63	T
10	UniProt	VAR_016783	D	68	A	ACY2_HUMAN	Disease (CAND)	---	A/B	D	68	A
11	UniProt	VAR_078090	L	69	R	ACY2_HUMAN	Disease (CAND)	776777887	A/B	L	69	R
12	UniProt	VAR_078091	G	101	V	ACY2_HUMAN	Disease (CAND)	---	A/B	G	101	V
13	UniProt	VAR_039081	D	114	E	ACY2_HUMAN	Disease (CAND)	---	A/B	D	114	E
14	UniProt	VAR_016784	D	114	Y	ACY2_HUMAN	Disease (CAND)	---	A/B	D	114	Y
15	UniProt	VAR_039082	G	123	E	ACY2_HUMAN	Disease (CAND)	---	A/B	G	123	E
16	UniProt	VAR_078092	E	129	K	ACY2_HUMAN	Disease (CAND)	773049803	A/B	E	129	K
17	UniProt	VAR_004995	I	143	T	ACY2_HUMAN	Disease (CAND)	777936704	A/B	I	143	T
18	UniProt	VAR_004996	C	152	R	ACY2_HUMAN	Disease (CAND)	104894548	A/B	C	152	R
19	UniProt	VAR_016785	C	152	W	ACY2_HUMAN	Disease (CAND)	---	A/B	C	152	W
20	UniProt	VAR_039083	C	152	Y	ACY2_HUMAN	Disease (CAND)	---	A/B	C	152	Y
21	UniProt	VAR_039084	R	168	C	ACY2_HUMAN	Disease (CAND)	---	A/B	R	168	C
22	UniProt	VAR_016780	R	168	H	ACY2_HUMAN	Disease (CAND)	770706390	A/B	R	168	H
23	UniProt	VAR_078093	I	170	T	ACY2_HUMAN	Disease (CAND)	144321760	A/B	I	170	T
24	UniProt	VAR_078094	I	177	T	ACY2_HUMAN	Disease (CAND)	---	A/B	I	177	T
25	UniProt	VAR_078095	G	180	V	ACY2_HUMAN	Disease (CAND)	---	A/B	G	180	V
26	UniProt	VAR_016781	P	181	T	ACY2_HUMAN	Disease (CAND)	786204572	A/B	P	181	T
27	UniProt	VAR_039085	P	183	H	ACY2_HUMAN	Disease (CAND)	---	A/B	P	183	H
28	UniProt	VAR_039086	V	186	F	ACY2_HUMAN	Disease (CAND)	---	A/B	V	186	F
29	UniProt	VAR_039087	M	195	R	ACY2_HUMAN	Disease (CAND)	---	A/B	M	195	R
30	UniProt	VAR_078096	D	204	H	ACY2_HUMAN	Disease (CAND)	---	A/B	D	204	H
31	UniProt	VAR_016786	Y	231	C	ACY2_HUMAN	Disease (CAND)	104894550	A/B	Y	231	C
32	UniProt	VAR_016787	H	244	R	ACY2_HUMAN	Disease (CAND)	---	A/B	H	244	R
33	UniProt	VAR_078097	Q	248	R	ACY2_HUMAN	Disease (CAND)	---	A/B	Q	248	R
34	UniProt	VAR_016788	D	249	V	ACY2_HUMAN	Disease (CAND)	104894552	A/B	D	249	V
35	UniProt	VAR_004998	G	274	R	ACY2_HUMAN	Disease (CAND)	761064915	A/B	G	274	R
36	UniProt	VAR_039088	P	280	L	ACY2_HUMAN	Disease (CAND)	---	A/B	P	280	L
37	UniProt	VAR_039089	P	280	S	ACY2_HUMAN	Disease (CAND)	750505963	A/B	P	280	S
38	UniProt	VAR_004999	E	285	A	ACY2_HUMAN	Disease (CAND)	28940279	A/B	E	285	A
39	UniProt	VAR_078098	A	286	D	ACY2_HUMAN	Disease (CAND)	---	A/B	A	286	D
40	UniProt	VAR_039090	A	287	T	ACY2_HUMAN	Disease (CAND)	774323189	A/B	A	287	T
41	UniProt	VAR_005000	F	295	S	ACY2_HUMAN	Disease (CAND)	---	A/B	F	295	S
42	UniProt	VAR_005001	A	305	E	ACY2_HUMAN	Disease (CAND)	28940574	A/B	A	305	E
43	UniProt	VAR_039091	C	310	G	ACY2_HUMAN	Polymorphism	376854191	A/B	C	310	G

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(no "PROSITE Motif" information available for 2Q51)

Asymmetric Unit (6, 12)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.2a	ENST00000263080	2a	ENSE00001116147	chr17:3379296-3379689	394	ACY2_HUMAN	1-79	79	2	A:9-79 B:9-79	71 71
1.3	ENST00000263080	3	ENSE00000669162	chr17:3384897-3385092	196	ACY2_HUMAN	79-144	66	2	A:79-144 B:79-144	66 66
1.4	ENST00000263080	4	ENSE00000669164	chr17:3386793-3386886	94	ACY2_HUMAN	145-176	32	2	A:145-176 B:145-176	32 32
1.5	ENST00000263080	5	ENSE00000669166	chr17:3392529-3392636	108	ACY2_HUMAN	176-212	37	2	A:176-212 B:176-212	37 37
1.6	ENST00000263080	6	ENSE00000669168	chr17:3397644-3397753	110	ACY2_HUMAN	212-248	37	2	A:212-248 B:212-248	37 37
1.7b	ENST00000263080	7b	ENSE00001923034	chr17:3402185-3406713	4529	ACY2_HUMAN	249-313	65	2	A:249-310 B:249-310	62 62

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:302
 aligned with ACY2_HUMAN | P45381 from UniProtKB/Swiss-Prot  Length:313

    Alignment length:302
                                    18        28        38        48        58        68        78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308  
           ACY2_HUMAN     9 EHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRC 310
               SCOP domains d2q51a_ A: Aspartoacylase AspA                                                                                                                                                                                                                                                                                 SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeee.....hhhhhhhhhhh..hhhhh......eeeee.hhhhhhhh......hhhhh.hhhhhh.......hhhhhhhhhhhhhh..........eeeeeee......eeeee....hhhhhhhhhhhhhhhh...eeeee.........hhhhhh...eeeee...............hhhhhhhhhhhhhhhhhh..........eeeeeeee..........eee..................eee....ee...............hhhhh..eeeeeee........... Sec.struct. author
             SAPs(SNPs) (1) -------T----P--G--R--P--------------------------T-----T----AR-------------------------------V------------E--------E-----K-------------T--------R---------------C-T------T--VT-H--F--------R--------H--------------------------C------------R---RV------------------------R-----L----ADT-------S---------E----G SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------K--------------------------------V--------------------------------------------------------Y-------------------------------------W---------------H---------------------------------------------------------------------------------------------------------------S------------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------------------------------------------------------------------------------------------------------------------------------Y-------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2a  PDB: A:9-79 UniProt: 1-79 [INCOMPLETE]                      -----------------------------------------------------------------Exon 1.4  PDB: A:145-176        -----------------------------------Exon 1.6  PDB: A:212-248             Exon 1.7b  PDB: A:249-310 UniProt: 249-313 [INCOMPLETE]        Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------Exon 1.3  PDB: A:79-144 UniProt: 79-144                           -------------------------------Exon 1.5  PDB: A:176-212             -------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 2q51 A   9 EHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKmSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNmGCTLILEDSRNNFLIQmFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQmRKmIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPmFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRC 310
                                    18        28        38        48        58        68        78   |    88        98       108       118   |   128       138|      148       158       168       178       188      |198       208       218       228       238       248       258  |    268       278       288       298       308  
                                                                                                    82-MSE                                 122-MSE          139-MSE                                                 195-MSE                                                           261-MSE                                             
                                                                                                                                                                                                                       198-MSE

Chain B from PDB  Type:PROTEIN  Length:302
 aligned with ACY2_HUMAN | P45381 from UniProtKB/Swiss-Prot  Length:313

    Alignment length:302
                                    18        28        38        48        58        68        78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308  
           ACY2_HUMAN     9 EHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRC 310
               SCOP domains d2q51b_ B: Aspartoacylase AspA                                                                                                                                                                                                                                                                                 SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) -AstE_AspA-2q51B01 B:10-301                                                                                                                                                                                                                                                                          --------- Pfam domains (1)
           Pfam domains (2) -AstE_AspA-2q51B02 B:10-301                                                                                                                                                                                                                                                                          --------- Pfam domains (2)
         Sec.struct. author ....eeeeee......hhhhhhhhhhhhhhhhh.....eeeeee.hhhhhhh.............hhhhhh.......hhhhhhhhhhhhhh..........eeeeeee.......eeee.....hhhhhhhhhhhhhhh.....eee.........hhhhhh.eeeeeee........hhhhhhhhhhhhhhhhhhhhhhhh......eeeeeeeeeeee............ee................eeee.....eee.............hhhhhhhh..eeeeeeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) -------T----P--G--R--P--------------------------T-----T----AR-------------------------------V------------E--------E-----K-------------T--------R---------------C-T------T--VT-H--F--------R--------H--------------------------C------------R---RV------------------------R-----L----ADT-------S---------E----G SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------K--------------------------------V--------------------------------------------------------Y-------------------------------------W---------------H---------------------------------------------------------------------------------------------------------------S------------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) -----------------------------------------------------------------------------------------------------------------------------------------------Y-------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2a  PDB: B:9-79 UniProt: 1-79 [INCOMPLETE]                      -----------------------------------------------------------------Exon 1.4  PDB: B:145-176        -----------------------------------Exon 1.6  PDB: B:212-248             Exon 1.7b  PDB: B:249-310 UniProt: 249-313 [INCOMPLETE]        Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------Exon 1.3  PDB: B:79-144 UniProt: 79-144                           -------------------------------Exon 1.5  PDB: B:176-212             -------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 2q51 B   9 EHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKmSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNmGCTLILEDSRNNFLIQmFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQmRKmIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPmFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRC 310
                                    18        28        38        48        58        68        78   |    88        98       108       118   |   128       138|      148       158       168       178       188      |198       208       218       228       238       248       258  |    268       278       288       298       308  
                                                                                                    82-MSE                                 122-MSE          139-MSE                                                 195-MSE                                                           261-MSE                                             
                                                                                                                                                                                                                       198-MSE

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Alpha and beta proteins (a/b) (23833)

Fold: Phosphorylase/hydrolase-like (558)

Superfamily: Zn-dependent exopeptidases (214)

Family: AstE/AspA-like (10)

Protein domain: Aspartoacylase AspA (5)

Human (Homo sapiens) [TaxId: 9606] (4)

1a	d2q51a_	A:
1b	d2q51b_	B:

(no "CATH Domain" information available for 2Q51)

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Peptidase_MH (119)

Family: AstE_AspA (12)

Homo sapiens (Human) (2)

1a	AstE_AspA-2q51B01	B:10-301
1b	AstE_AspA-2q51B02	B:10-301

Asymmetric Unit(hide GO term definitions)

Chain A,B (ACY2_HUMAN | P45381)

molecular function
	GO:0004046	aminoacylase activity	Catalysis of the reaction: an N-acyl-L-amino acid + H2O = a carboxylate + an L-amino acid.
	GO:0019807	aspartoacylase activity	Catalysis of the reaction: N-acyl-L-aspartate + H2O = a fatty acid anion + L-aspartate.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016811	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	Catalysis of the hydrolysis of any non-peptide carbon-nitrogen bond in a linear amide.
	GO:0016788	hydrolase activity, acting on ester bonds	Catalysis of the hydrolysis of any ester bond.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
biological process
	GO:0006533	aspartate catabolic process	The chemical reactions and pathways resulting in the breakdown of aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid.
	GO:0008652	cellular amino acid biosynthetic process	The chemical reactions and pathways resulting in the formation of amino acids, organic acids containing one or more amino substituents.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		MSE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		PO4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		ZN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Ala A:148 - Pro A:149	[ RasMol ]
		Ala B:148 - Pro B:149	[ RasMol ]
		Gly A:101 - Pro A:102	[ RasMol ]
		Gly A:180 - Pro A:181	[ RasMol ]
		Gly B:101 - Pro B:102	[ RasMol ]
		Gly B:180 - Pro B:181	[ RasMol ]

Biological Unit
	Complete Structure
		Biological Unit 1	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2q51
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ACY2_HUMAN \| P45381
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.5.1.15
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	271900
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ACY2_HUMAN \| P45381
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	ACY2_HUMAN \| P45381	:	2i3c 2o4h 2o53 4mri 4mxu 4nfr 4tnu

2gu2	ASPARTOACYLASE FROM RATTUS NORVEGICUS
2i3c	ORIGINAL REFINEMENT BASED ON SAME DATA AND R-FREE SET.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (3, 22)

Sites (10, 10)

SS Bonds (0, 0)

Cis Peptide Bonds (6, 96)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (43, 86)

PROSITE Motifs (0, 0)

Exons (6, 12)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (0, 0)

Pfam Domains (1, 2)

Gene Ontology (14, 14)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File